The George Institute for Global Health India today hosted a showcase of its SMARThealth technology, designed to help community health workers identify and treat people at high risk of chronic conditions such as diabetes and heart disease.
Sensyne Health has acquired the SUPPORT-HF™ digital health software developed by researchers at The George Institute for Global Health at the University of Oxford. SUPPORT-HF has been designed to help patients and clinicians in managing heart failure and curate data for medical research using clinical Artificial Intelligence (AI).
New research has found that long-term exposure to high blood pressure is associated with an increased risk of aortic valve disease, with significant implications for clinical practice guidelines and health management.
A new low dose three in one pill to treat hypertension could transform the way high blood pressure is treated around the world.
A trial led by The George Institute for Global Health revealed that most patients – 70 per cent – reached blood pressure targets with the ‘Triple Pill’, compared to just over half receiving normal care.